© Reuters.
In a strategic move, Avenue Therapeutics Inc . (NASDAQ: NASDAQ:) has announced a reverse stock split, as per a recent 8K SEC filing. Effective Tuesday, the majority of the company’s voting capital stockholders granted the board of directors discretionary authority to implement a reverse stock split at a ratio ranging from 30-for-1 to 75-for-1. The exact ratio is yet to be…
